21 CFR 212 - CURRENT GOOD MANUFACTURING PRACTICE FOR POSITRON EMISSION TOMOGRAPHY DRUGS
- SUBPART A — General Provisions (§§ 212.1 - 212.5)
- SUBPART B — Personnel and Resources (§§ 212.10 - 212.10)
- SUBPART C — Quality Assurance (§§ 212.20 - 212.20)
- SUBPART D — Facilities and Equipment (§§ 212.30 - 212.30)
- SUBPART E — Control of Components, Containers, and Closures (§§ 212.40 - 212.40)
- SUBPART F — Production and Process Controls (§§ 212.50 - 212.50)
- SUBPART G — Laboratory Controls (§§ 212.60 - 212.61)
- SUBPART H — Finished Drug Product Controls and Acceptance (§§ 212.70 - 212.71)
- SUBPART I — Packaging and Labeling (§§ 212.80 - 212.80)
- SUBPART J — Distribution (§§ 212.90 - 212.90)
- SUBPART K — Complaint Handling (§§ 212.100 - 212.100)
- SUBPART L — Records (§§ 212.110 - 212.110)
Source: 74 FR 65431, Dec. 10, 2009, unless otherwise noted.
Title 21 published on 2012-04-01
no entries appear in the Federal Register after this date.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
